Androgenic alopecia as Sars-Cov-2 aggravation
An Integrative Review
DOI:
https://doi.org/10.53843/bms.v5i8.213Keywords:
Hair, Androgens, Coronavirus InfectionAbstract
Introduction: The coronavirus pandemic highlights severe conditions associated to patients with androgenic alopecia, which is related to hormonal variation through the action of androgens. The present review aims to synthesize the evidence that correlates the role of androgens in androgenic alopecia in face of the coronavirus infection. Methodology: This literature review used the descriptors "Adult", "Alopecia" and "COVID-19" along with the Boolean operator "AND" in the bibliographic databases PubMed, SciELO, LILACS and BVS. The filters used were the languages English, Portuguese and Spanish and available full texts focussed on androgenic alopecia and the action of androgens in the pathophysiology of COVID-19. Results: After reading the selected articles, evidence was found about the implications of alopecia in the body, as well as the role of antiandrogens in the pathophysiology of COVID-19 and androgens in facilitating the passage of the virus into the intracellular environment. Discussion: SARS-CoV-2 infection occurs through the association between the virus's spike proteins and the transmembrane protease serine 2 (TMPRSS2) for its penetration into host cells. In addition, androgen receptors act as transcription promoters for TMPRSS2, making it easier for SARS-CoV-2 to enter the intracellular medium. Variations in the androgen receptor gene are related to its sensitivity and are associated with the development of diseases such as androgenic alopecia, a clinical condition that is being associated with severe COVID-19 prognosis and higher hospitalization rates. Conclusion: From the analyzed articles, it becomes evident not only the scarce number of scientific productions on the topic addressed, but also the association between androgenic alopecia and the worsening of COVID-19, in addition to the promising potential of therapies that use anti-androgenic drugs to treat SARS-CoV-2 infections.
Metrics
References
Moradi F, Enjezab B, Ghadiri-Anari A. The role of androgens in COVID-19. Diabetes Metab Syndr.[Internet] 2020 [Citado 2021 Maio 12];14(6):2003-2006. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33091758/
Johns Hopkins Coronavirus Resource Center. COVID-19 Map [Internet]. EUA: Johns Hopkins University & Medicine; 2021.[Citado 2021 Maio 12]; Disponível em: https://coronavirus.jhu.edu/map.html
Mohamed MS, Moulin TC, Schiöth, HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. [Internet] 2021 [Citado 2021 Maio 12]; 71, 3–8. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33179220/
Salazar Arenas MÁ, Muñoz Del Carpio-Toia A, Aybar Galdos J, Rodriguez-Morales AJ. Alopecia and severity of COVID-19: a cross-sectional study in Peru. J Infez Med [Internet]. 2021 Mar 1 [Citado 2021 Maio 12];29(1):37-45. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33664171/
Mirmirani P. Age-related hair changes in men: mechanisms and management of alopecia and graying. Maturitas[Internet]. 2015;80(1):58-62. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25466305/
Lobo I, Machado S, Selores M. A alopecia androgenética na consulta de tricologia do Hospital Geral de Santo António (cidade do Porto, Portugal) entre 2004 e 2006: estudo descritivo com componente analítico. A. Bras. Dermatol [Internet]. 2008;83(3):207-211. Disponível em: https://www.scielo.br/j/abd/a/DnHvX5d6JrYKzTPYHdWrPcz/?lang=pt
Gao C, Zhao Z, Li F, Liu Jl, Xu H, et al. The impact of individual lifestyle and status on the acquisition of COVID-19: A case-Control study.[Internet] PLOS ONE. 2020 Nov; 15(11): e0241540. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33152004/
Goren A, Wambier CG, Herrera S, et al. Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Eur Acad Dermatol Venereol.[Internet] 2021 Jan;35(1):e13-e15. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32977363/
McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A. Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. J Eur Acad Dermatol Venereol [Internet]. 2021 Jan;35(1):e15-e17. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32977355/
Wambier CG, Vaño-Galván S, McCoy J, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign". J Am Acad Dermatol.[Internet] 2020;83(2):680-682. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32446821/
Trüeb RM, Dutra Rezende H, Gavazzoni Dias MFR. What can the hair tell us about COVID-19? Exp Dermatol.[Internet] 2021 Fev [Citado 2021 Maio 13] ;30(2):288-290. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33316115/
Al Aboud AM, Zito PM. Alopecia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Thamires da Silva Sampaio Medrado, Marcela Vasconcelos Montenegro, Rafael Cabral de Carli, Tatiane Lins Carvalho
This work is licensed under a Creative Commons Attribution 4.0 International License.
User licenses define how readers and the general public can use the article without needing other permissions. The Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders can use to share original works of authorship and other material subjects to copyright and certain other rights specified in the public license available at https:// creativecommons.org/licenses/by/4.0/deed.pt_BR. Using the 4.0 International Public License, Brazilian Medical Students (BMS) grants the public permission to use published material under specified terms and conditions agreed to by the journal. By exercising the licensed rights, authors accept and agree to abide by the terms and conditions of the Creative Commons Attribution 4.0 International Public License.